Evidence map›Paper›PMID 39971949›Full record

ArticleBlood cancer journal2025

Effect of pre-transplant cytoreductive therapy on the outcomes of patients with MDS or secondary AML evolving from MDS undergoing allo-HSCT: a secondary analysis of an RCT.

Rongtao Xue, Min Dai, Erlie Jiang, Xueying Ou, Fen Huang, Zhiping Fan, Na Xu, Chenhua Yan, Danian Nie, Xinquan Liang and 12 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Rongtao Xue *Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Min Dai *Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Erlie Jiang *Hematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China.ORCID http://orcid.org/0000-0003-0237-6063
Xueying Ou *Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Fen HuangDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zhiping FanDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Na XuDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Chenhua YanDepartment of Hematology, Peking University People's Hospital, Beijing, China.
Danian NieDepartment of Hematology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Xinquan LiangDepartment of Hematology, the First People's Hospital of Chenzhou, Chenzhou, China.
Hong ChenDepartment of Hematology, Liuzhou Worker's Hospital, Liuzhou, China.
Jieyu YeDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Ling JiangDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Hui LiuDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Hua JinDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Ren LinDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Yu ZhangDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Jing SunDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Mingzhe HanHematopoietic Stem Cell Transplantation Center, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, Tianjin, China.ORCID http://orcid.org/0000-0002-1720-6799
Qifa LiuDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China. liuqifa628@163.com.ORCID http://orcid.org/0000-0003-4015-3952
Yu WangDepartment of Hematology, Peking University People's Hospital, Beijing, China. ywyw3172@sina.com.ORCID http://orcid.org/0000-0003-1253-7465
Li XuanDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China. 356135708@qq.com.ORCID http://orcid.org/0000-0002-6176-7411

Funding

National Natural Science Foundation of China (National Science Foundation of China) No. 82170213, 82370216Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) No. 2024A1515010794
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39971949
PMCPMC11840129

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.